Manufacturer record
Cadila Pharmaceuticals Limited: regulatory record
Last checked 3 November 2026. Source: CDSCO monthly NSQ alerts and state drug-testing laboratories
14 batches manufactured by Cadila Pharmaceuticals Limited (Gujarat) were declared Not of Standard Quality between January 2019 and November 2025. Records are batch-specific findings by government laboratories as published in CDSCO's monthly alerts; where a company has stated that a flagged batch was counterfeit, that statement is noted when reported.
Most recent flagged batch: JKBD24080, Ciprofloxacin Hydrochloride Tablets IP 500 mg (exp Jul 2027). DTL Thiruvananthapuram (state lab) found it not of standard quality: The sample does not conform to IP Standards, It fails the test ' Dissolution' as per IP. Listed in the November 2025 alert.
Records by type
14 records linked to Cadila Pharmaceuticals Limited in the datasets we hold. A zero means nothing is on record in those datasets, not that nothing ever happened. What the labels mean.
CDSCO drug alerts: Not of Standard Quality and spurious drugs
Scope. A company appearing here is not a finding that its products are unsafe. Regulatory actions can apply to one batch, one formulation, one period or one state. Always check the linked government document for the current position, and tell us if something is out of date. How we label records.
Flagged batches per year
All flagged batches
| Product | Batch | Reason declared NSQ | Tested by | Alert |
|---|---|---|---|---|
| Ciprofloxacin Hydrochloride Tablets IP 500 mg | Batch JKBD24080Mfg Aug 2024 · Exp Jul 2027 | The sample does not conform to IP Standards, It fails the test ' Dissolution' as per IP.Dissolution | DTL ThiruvananthapuramState lab | Nov 2025 |
| Ciprofloxacin Tablets IP 250 mg (Ciprodac 250) | Batch CT24001Mfg Feb 2024 · Exp Jan 2027 | Dissolution" of CiprofloxacinDissolution | RDTL GuwahatiCDSCO lab | Apr 2025 |
| CIPRODAC 500 (Ciprofloxacin Tablets IP 500mg) | Batch AN24014Mfg Jan 2024 · Exp Dec 2026 | The Sample does not conform to standard in respect of the test "Dissolution" performedDissolution | SDTL Agartala, TripuraState lab | Dec 2024 |
| Ciprofloxacin Tablets IP 500 mg (CIPRODAC 500) | Batch JKBD24009Mfg Jan 2024 · Exp Dec 2026 | Dissolution of CiprofloxacinDissolution | RDTL GuwahatiCDSCO lab | Sep 2024 |
| RANITIDINE TABLETS IP 150mg (ACILOC 150) | Batch LD21512Mfg Oct 2021 · Exp Mar 2024 | DescriptionDescription | RDTL GuwahatiState lab | Jun 2023 |
| Tinvista 300 (Tinidazole Tablets I.P. 300 mg) | Batch JKGJ20001Mfg Mar 2020 · Exp Feb 2024 | DisintegrationDisintegration | CDL KolkataCDSCO lab | May 2023 |
| Ranitidine Tablets IP 150 mg (ACILOC 150) | Batch LD22114Mfg Feb 2022 · Exp Jul 2024 | DescriptionDescription | RDTL GuwahatiState lab | Sep 2022 |
| ACILOC 150 (RANITIDINE TABLETS IP 150 mg) | Batch LD21599Mfg Dec 2021 · Exp May 2024 | DescriptionDescription | RDTL GuwahatiState lab | Sep 2022 |
| CALNIF RETARD (Nifedipine Prolonged Release Tablets I.P. 20 mg) | Batch JKEG21006Mfg Jul 2021 · Exp Jun 2024 | DissolutionDissolution | CDL KolkataCDSCO lab | May 2022 |
| TINVISTA 300 (Tinidazole Tablets IP 300 mg) | Batch JKGJ20001Mfg Mar 2020 · Exp Feb 2024 | DisintegrationDisintegration | CDTL MumbaiCDSCO lab | Mar 2022 |
| Pantoprazole & Domperidone Tablets (PENTALOC-D) | Batch JK19006Mfg Aug 2019 · Exp Jul 2022 | DissolutionDissolution | RDTL GuwahatiCDSCO lab | Sep 2021 |
| Ranitidine Injection IP 25mg/ml (ACILOC Injection) | Batch RP20139Mfg Jun 2020 · Exp May 2023 | Particulate MatterParticulate matter | RDTL ChandigarhState lab | Nov 2020 |
| STOPVOM (Domperidone Tablets IP 10 mg) | Batch JK17001Mfg Jan 2017 · Exp Dec 2019 | DissolutionDissolution | CDL KolkataCDSCO lab | Mar 2019 |
| Stopvom (Domperidone Tablets I.P. 10 mg) | Batch JK17001Mfg Jan 2017 · Exp Dec 2019 | DissolutionDissolution | CDL KolkataCDSCO lab | Jan 2019 |
Right of reply. Manufacturers may submit a response or a laboratory re-test result; it is published unedited alongside this record. Submit a response.